Simplex Trading
FPRX

Simplex Trading’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Simplex Trading’s Portfolio FPRX Stock Details FPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-93
Closed -$158K – 10540
2020
Q4 		$158K Buy
93
+54
+138% +$677 ﹤0.01% 4926
2020
Q3 		$18K Sell
39
-141
-78% -$716 ﹤0.01% 6443
2020
Q2 		$109K Buy
180
+58
+48% +$239 ﹤0.01% 4714
2020
Q1 		$27K Buy
122
+113
+1,256% +$480 ﹤0.01% 5725
2019
Q4 		$4K Buy
+9
New +$36 ﹤0.01% 6830
2019
Q3 		– Sell
-3
Closed -$1K – 8181
2019
Q2 		$1K Sell
3
-54
-95% -$516 ﹤0.01% 6952
2019
Q1 		$76K Buy
57
+26
+84% +$297 ﹤0.01% 4628
2018
Q4 		$28K Sell
31
-9
-23% -$107 ﹤0.01% 5070
2018
Q3 		$55K Buy
40
+19
+90% +$283 ﹤0.01% 5079
2018
Q2 		$33K Buy
+21
New +$366 ﹤0.01% 5467
2017
Q2 		– Sell
-52
Closed -$9K – 7102
2017
Q1 		$9K Buy
+52
New +$2.29K ﹤0.01% 4110
2016
Q2 		– Sell
-24
Closed -$16K – 6709
2016
Q1 		$16K Buy
24
+15
+167% +$516 ﹤0.01% 3026
2015
Q4 		$9K Buy
+9
New +$302 ﹤0.01% 3440

Simplex Trading's FPRX Position: Q2 2021 in Review

Simplex Trading sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2021, closing a stake of 13,118 shares.

Simplex Trading first reported a position in FPRX in Q3 2015 and held it in 16 quarters. The position peaked at $308K in Q2 2018. 0 funds tracked by Wall St. Rank hold FPRX as of Q2 2021.

  • Simplex Trading reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
  • Simplex Trading sold 13,118 Five Prime Therapeutics, Inc. shares in Q2 2021.
  • Simplex Trading first reported a position in Five Prime Therapeutics, Inc. in Q3 2015 and held it in 16 quarters.
  • Simplex Trading's Five Prime Therapeutics, Inc. position peaked at $308K in Q2 2018.
  • 0 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2021.

Based on Simplex Trading's 13F filing for Q2 2021, filed 12 Aug 2021.